<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>During the last two years oral contraceptives containing gestodene were suspected to cause cerebrovascular disorders </plain></SENT>
<SENT sid="1" pm="."><plain>52 cases with adverse neurological side effects were registered up to October 31, 1990 </plain></SENT>
<SENT sid="2" pm="."><plain>Anonymous protocols received from the Companies Schering AG and Wyeth Pharma were analyzed from a clinical point of view </plain></SENT>
<SENT sid="3" pm="."><plain>There are different arterial and venous, thrombotic and embolic disorders caused by different pathogenetic principles </plain></SENT>
<SENT sid="4" pm="."><plain>Only one third of the cases was documented by neuro-imaging to render possible actual diagnostic reliability </plain></SENT>
<SENT sid="5" pm="."><plain>Suspected cases represent a great number of different cerebrovascular disorders usually observed in neurological and neurosurgical series, concerning both men and women, OC-users and non users </plain></SENT>
</text></document>